Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
7
39%
Ph not_applicable
5
28%
Ph phase_3
3
17%
Ph phase_4
2
11%

Phase Distribution

7

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
7(41.2%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
2(11.8%)
N/ANon-phased studies
5(29.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

18

all time

Status Distribution
Active(2)
Completed(8)
Terminated(2)
Other(6)

Detailed Status

Completed8
unknown6
Withdrawn2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
18
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (41.2%)
Phase 33 (17.6%)
Phase 42 (11.8%)
N/A5 (29.4%)

Trials by Status

unknown633%
completed844%
withdrawn211%
recruiting211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07525791Phase 1

A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

Recruiting
NCT06889454

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

Recruiting
NCT07071389Not Applicable

Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives

Withdrawn
NCT05340634Phase 4

Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.

Completed
NCT04934696Phase 1

A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential

Completed
NCT03843736Phase 3

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

Unknown
NCT03783897Phase 1

A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

Completed
NCT03506399Phase 1

A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

Withdrawn
NCT03230825Not Applicable

Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products

Unknown
NCT02480881Phase 1

A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)

Completed
NCT02494609Phase 1

Oral Contraceptive DDI Study

Unknown
NCT02257671Not Applicable

Oral Contraceptives and Economic Behaviour

Unknown
NCT00229996Phase 3

Medical Treatment of Endometriosis-Associated Pelvic Pain

Completed
NCT01414530Not Applicable

Oral Contraceptive During Menopausal Transition

Unknown
NCT01798875Phase 4

PCOS, Therapy and Markers of Cardiovascular Risk

Unknown
NCT01714193Phase 1

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers

Completed
NCT00842140Not Applicable

Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women

Completed
NCT00948402Phase 3

PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18